MetLife Investment Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $324K | Buy |
15,881
+152
| +1% | +$3.1K | ﹤0.01% | 1909 |
|
|
2025
Q1 | $315K | Sell |
15,729
-288
| -2% | -$5.77K | ﹤0.01% | 1946 |
|
|
2024
Q4 | $427K | Buy |
16,017
+1,645
| +11% | +$43.8K | ﹤0.01% | 1887 |
|
|
2024
Q3 | $410K | Hold |
14,372
| – | – | ﹤0.01% | 1887 |
|
|
2024
Q2 | $313K | Buy |
14,372
+2,003
| +16% | +$43.6K | ﹤0.01% | 1982 |
|
|
2024
Q1 | $274K | Hold |
12,369
| – | – | ﹤0.01% | 2009 |
|
|
2023
Q4 | $267K | Hold |
12,369
| – | – | ﹤0.01% | 2070 |
|
|
2023
Q3 | $209K | Hold |
12,369
| – | – | ﹤0.01% | 2181 |
|
|
2023
Q2 | $170K | Hold |
12,369
| – | – | ﹤0.01% | 2379 |
|
|
2023
Q1 | $281K | Hold |
12,369
| – | – | ﹤0.01% | 2008 |
|
|
2022
Q4 | $291K | Hold |
12,369
| – | – | ﹤0.01% | 2010 |
|
|
2022
Q3 | $323K | Hold |
12,369
| – | – | ﹤0.01% | 1955 |
|
|
2022
Q2 | $272K | Hold |
12,369
| – | – | ﹤0.01% | 2093 |
|
|
2022
Q1 | $555K | Buy |
12,369
+4,565
| +58% | +$205K | ﹤0.01% | 1708 |
|
|
2021
Q4 | $335K | Hold |
7,804
| – | – | ﹤0.01% | 1737 |
|
|
2021
Q3 | $519K | Hold |
7,804
| – | – | ﹤0.01% | 1499 |
|
|
2021
Q2 | $572K | Buy |
7,804
+2,020
| +35% | +$148K | 0.01% | 1488 |
|
|
2021
Q1 | $396K | Buy |
5,784
+1,176
| +26% | +$80.5K | ﹤0.01% | 1660 |
|
|
2020
Q4 | $309K | Hold |
4,608
| – | – | ﹤0.01% | 1753 |
|
|
2020
Q3 | $237K | Hold |
4,608
| – | – | ﹤0.01% | 1762 |
|
|
2020
Q2 | $174K | Hold |
4,608
| – | – | ﹤0.01% | 1987 |
|
|
2020
Q1 | $137K | Buy |
+4,608
| New | +$137K | ﹤0.01% | 1896 |
|